Xilio Therapeutics, Inc.
XLO
$8.95
$0.040.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 136.04M | 150.33M | 137.53M | 103.76M | 121.55M |
| Total Receivables | 6.00M | -- | 5.00M | 17.50M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.43M | 3.87M | 2.50M | 2.83M | 2.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 145.47M | 154.21M | 145.03M | 124.09M | 123.72M |
|
|
|||||
| Total Current Assets | 145.47M | 154.21M | 145.03M | 124.09M | 123.72M |
| Net Property, Plant & Equipment | 6.97M | 7.47M | 7.85M | 7.80M | 8.30M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.82M | 1.81M | 1.81M | 1.80M | 1.79M |
| Total Assets | 154.25M | 163.49M | 154.69M | 133.69M | 133.81M |
|
|
|||||
| Total Accounts Payable | 2.32M | 1.06M | 3.17M | 2.30M | 4.10M |
| Total Accrued Expenses | 7.85M | 8.97M | 11.74M | 8.95M | 5.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.43M | 1.38M | 1.34M | 1.30M | 1.26M |
| Total Finance Division Other Current Liabilities | 22.60M | 31.54M | 40.02M | 43.85M | 42.28M |
| Total Other Current Liabilities | 22.60M | 31.54M | 40.02M | 43.85M | 42.28M |
| Total Current Liabilities | 34.20M | 42.96M | 56.27M | 56.40M | 53.26M |
|
|
|||||
| Total Current Liabilities | 34.20M | 42.96M | 56.27M | 56.40M | 53.26M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.88M | 5.25M | 5.61M | 5.96M | 6.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 42.92M | 42.73M | 57.53M | 79.43M | 67.18M |
| Total Liabilities | 81.99M | 90.94M | 119.41M | 141.79M | 126.74M |
|
|
|||||
| Common Stock & APIC | 506.96M | 500.86M | 454.06M | 421.05M | 419.93M |
| Retained Earnings | -434.69M | -428.32M | -418.79M | -429.15M | -412.86M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 72.26M | 72.55M | 35.27M | -8.10M | 7.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 72.26M | 72.55M | 35.27M | -8.10M | 7.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 72.26M | 72.55M | 35.27M | -8.10M | 7.07M |
|
|
|||||